How come CBD isn’t use by more doctors. My mom is sick from cancer and her doctor said he didn’t recommend it. But I know a lot of other doctors do?
Admin_1
Helen
Thank you for your question. Many Doctors site a lack of clinical evidence as to why CBD isn’t used to treat their patients. But in reality it is much more complicated than that. While there are many anecdotal reports and preliminary studies suggesting that CBD may help with conditions such as anxiety, chronic pain, and epilepsy, there is a lack of large-scale, clinical trials that provide definitive proof of its efficacy and safety for various medical conditions.
The U.S. Food and Drug Administration (FDA) has only approved one CBD-based medication, Epidiolex, for the treatment of rare forms of epilepsy. The approval of Epidiolex is based on comprehensive clinical trials. For other uses, CBD lacks the extensive clinical validation required for widespread medical endorsement.
Regulation is another reason for inconsistencies in treatments. The CBD market is largely unregulated, leading to concerns about product consistency, quality, and safety. Products can vary significantly in terms of CBD concentration, purity, and the presence of contaminants. While the 2018 Farm Bill legalized hemp-derived CBD (containing less than 0.3% THC), the regulatory landscape is still complex. State laws vary, and the FDA has not established clear guidelines for CBD as a dietary supplement or food additive.
The medical community is still skeptical and have adopted a cautious approach when it comes to prescribing treatments that lack substantial clinical evidence. They rely on established medications with known efficacy and safety profiles. Many healthcare providers may not have adequate training or knowledge about CBD and its potential benefits and risks. Medical education often lags behind emerging treatments, particularly those derived from substances like cannabis, which have historically been stigmatized and heavily regulated.
There are other factors to consider as well such as: Interactions with Other Medications, lack of standardization, product quality, insurance and cost issues.
While CBD holds promise as a therapeutic agent for various conditions, and the landscape surround the use of CBD is growing, its use by doctors is still limited due to a lack of clinical testing, regulatory challenges, potential drug interactions, and issues with product standardization and quality. Addressing these concerns through more research, regulatory clarity, education, and improved product quality can pave the way for broader acceptance and use of CBD in medical practice.
Please keep in mind, many physicians do recommend CBD use especially in cancer patients. So there is no reason you shouldn’t seek a second or third opinion in your mother’s case, you might be pleasantly surprised. All the best to your mother, you and your family.
2 responses to “CBD Discussion”
How come CBD isn’t use by more doctors. My mom is sick from cancer and her doctor said he didn’t recommend it. But I know a lot of other doctors do?
Helen
Thank you for your question. Many Doctors site a lack of clinical evidence as to why CBD isn’t used to treat their patients. But in reality it is much more complicated than that. While there are many anecdotal reports and preliminary studies suggesting that CBD may help with conditions such as anxiety, chronic pain, and epilepsy, there is a lack of large-scale, clinical trials that provide definitive proof of its efficacy and safety for various medical conditions.
The U.S. Food and Drug Administration (FDA) has only approved one CBD-based medication, Epidiolex, for the treatment of rare forms of epilepsy. The approval of Epidiolex is based on comprehensive clinical trials. For other uses, CBD lacks the extensive clinical validation required for widespread medical endorsement.
Regulation is another reason for inconsistencies in treatments. The CBD market is largely unregulated, leading to concerns about product consistency, quality, and safety. Products can vary significantly in terms of CBD concentration, purity, and the presence of contaminants. While the 2018 Farm Bill legalized hemp-derived CBD (containing less than 0.3% THC), the regulatory landscape is still complex. State laws vary, and the FDA has not established clear guidelines for CBD as a dietary supplement or food additive.
The medical community is still skeptical and have adopted a cautious approach when it comes to prescribing treatments that lack substantial clinical evidence. They rely on established medications with known efficacy and safety profiles. Many healthcare providers may not have adequate training or knowledge about CBD and its potential benefits and risks. Medical education often lags behind emerging treatments, particularly those derived from substances like cannabis, which have historically been stigmatized and heavily regulated.
There are other factors to consider as well such as: Interactions with Other Medications, lack of standardization, product quality, insurance and cost issues.
While CBD holds promise as a therapeutic agent for various conditions, and the landscape surround the use of CBD is growing, its use by doctors is still limited due to a lack of clinical testing, regulatory challenges, potential drug interactions, and issues with product standardization and quality. Addressing these concerns through more research, regulatory clarity, education, and improved product quality can pave the way for broader acceptance and use of CBD in medical practice.
Please keep in mind, many physicians do recommend CBD use especially in cancer patients. So there is no reason you shouldn’t seek a second or third opinion in your mother’s case, you might be pleasantly surprised. All the best to your mother, you and your family.